Preoperative aspirin use and outcomes in cardiac surgery patients

Annals of Surgery

Volumn 255, Issue 2, 2012, Pages 399-404

  Cao, Longhui ^a,f   Young, Nilas ^c   Liu, Hong ^d   Silvestry, Scott ^b   Sun, Will ^a   Zhao, Ning ^e   Diehl, James ^b   Sun, Jianzhong ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c Division of Cardiothoracic Surgery   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; RENIN INHIBITOR;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIALYSIS; DRUG EFFECT; DRUG USE; FEMALE; HEART INFARCTION; HEART PROTECTION; HEART SURGERY; HOSPITAL READMISSION; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SENESCENCE; SEX DIFFERENCE;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CARDIOVASCULAR SURGICAL PROCEDURES; FEMALE; HEART DISEASES; HUMANS; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; OBSERVATION; PATIENT READMISSION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84855824003     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318234313b     Document Type: Article

References (33)

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ. 2002;324:71-86.
2. Becker RC. Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis. Am J Med. 2008;121:43-49.
3. Awtry EH, Loscalzo J. Aspirin. Circulation. 2000;101:1206-1218. (Pubitemid 30146625)
4. Tran H, Anand SS. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. JAMA. 2004;292: 1867-1874. (Pubitemid 40169298)
5. Chesebro JH, Clements IP, Fuster V, et al. A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med. 1982;307:73-78. (Pubitemid 12082584)
6. Goldman S, Copeland J, Moritz T, et al. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study. Circulation. 1989;80:1190-1197.
7. Sun JC, Teoh KH, Lamy A, et al. Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study. Am Heart J. 2010;160: 1178-11784.
8. Kulik A, Le May MR, Voisine P, et al. Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) Trial. Circulation. 2010;122: 2680-2387.
9. Mangano DT. Multicenter Study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med. 2002;347:1309-1317. (Pubitemid 35215321)
10. Kim DH, Daskalakis C, Silvestry SC, et al. Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2009;138:1377-1384.
11. Dacey LJ, Munoz JJ, Johnson ER, et al. Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients. Ann Thorac Surg. 2000;70:1986-1990. (Pubitemid 32015295)
12. Bybee KA, Powell BD,ValetiU, et al. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting. Circulation. 2005;112:I286-I292. (Pubitemid 41266689)
13. Jacob M, Smedira N, Blackstone E, et al. Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in coronary artery bypass surgery. Circulation. 2011;123:577-583.
14. Berger JS. Platelet-directed therapies and coronary artery bypass grafting. Am J Cardiol. 2009;104:44C-48C.
15. Sun JC, Whitlock R, Cheng J, et al. The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies. Eur Heart J. 2008;29:1057-1071. (Pubitemid 351858412)
16. Kulik A, Chan V, Ruel M. Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy. Expert Opin Drug Saf. 2009;8:169-182.
17. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation. 2004;110:1168-1176.
18. Ferraris VA, Ferraris SP, Moliterno DJ, et al. The society of thoracic surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary). Ann Thorac Surg. 2005;79:1454-1461. (Pubitemid 40431898)
19. Dunning J, Versteegh M, Fabbri A, et al. Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg. 2008;34: 73-92.
20. Ferguson TB Jr, Coombs LP, Peterson ED. Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA. 2002;287:2221-2227. (Pubitemid 34441938)
21. Barodka V, Silvestry S, Zhao N, et al. Preoperative renin-angiotensin system inhibitors protect renal function in aging patients undergoing cardiac surgery. J Surg Res. 2011;167:e63-e69.
22. D'Agostino RB Jr. Propensity scores in cardiovascular research. Circulation. 2007;115:2340-2343. (Pubitemid 46685902)
23. Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res. 2003;110:255-258. (Pubitemid 37329821)
24. The International StrokeTrial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischemic stroke. International Stroke Trial Collaborative Group. Lancet. 1997;349:1569-1581.
25. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988;2:349-360.
26. King SB III, Smith SC Jr, Hirshfeld JW Jr, et al. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation. 2008;117:261-295.
27. Stein PD, Scḧunemann HJ, Dalen JE, et al. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:600S-608S. (Pubitemid 39297964)
28. Cao LH, Kandiah N, Silvestry S, et al. Does preoperative aspirin reduce cardiocerebral ischemic events in cardiac surgery patients? (Abstract: A1190). Paper presented at: ASA Annual Meeting; 2010; San Diego, CA.
29. Winkelmayer WC, Kurth T. Propensity scores: help or hype? Nephrol Dial Transplant. 2004;19:1671-1673. (Pubitemid 38961371)
30. Myles PS, Smith J, Knight J, et al. ATACAS trial group. aspirin and tranexamic acid for coronary artery surgery (ATACAS) Trial: rationale and design. Am Heart J. 2008;155:224-230.
31. Hannan EL. Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations. JACC Cardiovasc Interv. 2008;1:211-217. (Pubitemid 351804181)
32. McIlroy DR, Myles PS, Phillips LE, et al. Antifibrinolytics in cardiac surgical patients receiving aspirin: a systematic review andmeta-analysis. Br J Anaesth. 2009;102:168-178.
33. Yusuf S, Wittes J, Probstfield J, et al. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA. 1991;266:93-98.